Ignite Creation Date:
2025-12-25 @ 12:30 AM
Ignite Modification Date:
2026-03-07 @ 10:18 PM
Study NCT ID:
NCT01251367
Status:
COMPLETED
Last Update Posted:
2022-09-28
First Post:
2010-11-25
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Dysport® Adult Lower Limb Spasticity Follow-on Study
Sponsor:
Ipsen
Organization:
Study Overview
Official Title:
A Phase III, Prospective, Multicentre, Open Label, Extension Study, to Assess the Long Term Safety and Efficacy of Repeated Treatment of Dysport® Intramuscular Injection in the Treatment of Lower Limb Spasticity in Adult Subjects With Spastic Hemiparesis Due to Stroke or Traumatic Brain Injury
Status:
COMPLETED
Status Verified Date:
2022-09
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The purpose of this research study is to assess the long term safety of Dysport® in hemiparetic subjects with lower limb spasticity due to stroke or traumatic brain injury over repeated treatment cycles.
Detailed Description:
None
Study Oversight
Has Oversight DMC:
False
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
Secondary ID Infos
| Secondary ID | Type | Domain | Link | View |
|---|---|---|---|---|
| 2009-017723-26 | EUDRACT_NUMBER | None | View |